News

Insider Media3h
Shift Bioscience makes double appointment to support long-term strategy for cell rejuvenation therapeutics
Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...
Cambridge Network22h
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced ...
Business Weekly23h
Shift Bioscience onboards Lord Prior and Sir Tony Kouzarides to back growth strategy
Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...
Contract Pharma18h
Shift Bioscience Announces Board and Advisor Appointments
Shift Bioscience (Shift), a biotech company using an AI-powered virtual cell to fight age-driven diseases, appointed Lord ...
Dan Ives on Tesla: This is a watershed moment for autonomy, more bullish after hearing Elon Musk
Dan Ives, Wedbush Securities, and Bryn Talkington, Requisite Capital, join 'Closing Bell' to discuss Elon Musk's interview ...
The National on MSN12h
Fed officials suggest pause on rate cuts could extend further
Officials at the US Federal Reserve are signalling that their pause on cutting interest rates could be further extended as uncertainty continues to grip the economic outlook. “Economic policy ...